www.fdanews.com/articles/120740-keryx-kidney-drug-meets-goals-in-midstage-study

Keryx Kidney Drug Meets Goals in Midstage Study

September 24, 2009

Keryx Biopharmaceuticals Inc. said its developing kidney disease drug Zerenex met safety and tolerability goals in a midstage study.
Yahoo! Finance